OVERVIEW

Please be sure to scroll to the bottom of the page and click Continue to begin.

One of every four US women has an abortion and at least as many have a miscarriage.  In a growing number of communities, women need to travel considerable distances to obtain clinical assistance with an abortion or miscarriage.  Such travel is a particular burden for rural and low-income women. Both early abortion and miscarriage can be managed with a single dose of oral mifepristone followed by misoprostol. Many patients prefer to receive these family planning services from their trusted primary care provider.

Curriculum for online training

This activity is designed to increase primary care providers' ability to counsel patients about using mifepristone to terminate an early pregnancy. This involves:

• Identifying patients who can safely use mifepristone;
• Counseling patients how to take the medications;
• Evaluating patients with possible side-effects.

  FACULTY

	Eleanor Bimla Schwarz, MD, MS (Course Director) Professor of Medicine University of California, Davis Sacramento, California
	Mindy Sobota, MD, MS, MPhil Associate Professor of Medicine, and Clinician Educator Brown University Alpert Medical School Providence, Rhode Island
	Suzan Goodman, MD, MPH Clinical Professor of Family and Community Medicine Zuckerberg San Francisco General TEACH Program Curriculum Director, Bixby Center for Global Reproductive Health UCSF School of Medicine San Francisco, California
	Clinical Reviewers
	Jessica Beaman, MD, MPH, Assistant Professor of Medicine; UCSF School of Medciine Courtney Benedict, CNM, MSN, Associate Director, Medical Standards Implementation; Planned Parenthood Federation of America Rachel S. Casas, MD, EdM, Assistant Professor of Medicine; Penn State College of Medicine Cynthia H. Chuang, MD, MSc, Chief, Division of General Internal Medicine; Professor of Medicine and Public Health Sciences; Penn State College of Medicine Daniel Grossman, MD, Professor of Obstetrics, Gynecology & Reproductive Sciences; Director, Advancing New Standards in Reproductive Health (ANSIRH), UCSF School of Medicine Ivonne McLean, MD, Faculty Attending, Community Family Health Center, New York; Reproductive Health Access Project (RHAP) Provider Christine Prifti, MD, Instructor of Medicine, Boston University School of Medicine

  DISCLOSURE

This UCSF CME educational activity was planned and developed to: uphold academic standards to ensure balance, independence, objectivity, and scientific rigor; adhere to requirements to protect health information under the Health Insurance Portability and Accountability Act of 1996 (HIPAA); and, include a mechanism to inform learners when unapproved or unlabeled uses of therapeutic products or agents are discussed or referenced.

This activity has been reviewed and approved by members of the UCSF CME Governing Board in accordance with UCSF CME accreditation policies. Office of CME staff, planners, reviewers, and all others in control of content of this particular activity have disclosed no relevant financial relationships.

The listed faculty presenters, reviewers, actors and content planners have disclosed they have no relevant financial relationships with ineligible entities whose primary business is the production, distribution, selling, re-selling of health care goods used by or on patients.

  ACCREDITATION

The University of California, San Francisco is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians: This enduring material activity has been approved for a maximum of 1.0 AMA PRA Category 1 Credit.^TM Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse Practitioners and Registered Nurses: For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 Credit™ issued by organizations accredited by the ACCME.

Physician Assistants: The National Commission on Certification of Physician Assistants (NCCPA) states that the AMA PRA Category 1 Credits™ are acceptable for continuing medical education requirements for recertification.

California Pharmacists: The California Board of Pharmacy accepts as continuing professional education those courses that meet the standard of relevance to pharmacy practice and have been approved for AMA PRA Category 1 Credit™. If you are a pharmacist in another state, you should check with your state board for approval of this credit.

This CME activity meets the requirements under California Assembly Bill 1195, continuing education and cultural and linguistic competency.

  GENERAL INFORMATION

Requirements
An Internet connection, up-to-date web browser, Adobe Acrobat Reader*, and video streaming capability are required to participate in this course. _{*Required only to view printable (PDF) materials.}

Fees

The cost to participate in the online training for CE credit is $60.

This activity is not commercially supported, however it does generically refer to a specific product.

Certification Dates
Begins: September 22, 2022

Expires: September 21, 2025

Cancellations and Refunds
Cancellations should be made in writing within 7 days of enrollment. Refunds will only be made in the event that technical difficulties prevent completion of the activity, or if no interaction with the material occurred because of inadvertent or mistaken enrollment, or expiration of the activity before the learner had the opportunity to complete it fully. Fees can be transferred to another activity in the case of mistaken enrollment.

Special Needs or Other Concerns
If you require any special accommodations for a disability which creates a hardship to participating in this activity, or you have questions or concerns about this course, please contact the Office of CME. (Additional contact information is below.)

Cultural and Linguistic Competency Resources

CLC Info and Resources

UC Online Privacy Policy
http://meded.ucsf.edu/cme/privacy-policy